Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Carbone

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
Lung|March 14, 2024
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung CancerDavide Ramoni, Simona Coco, Giovanni Rossi, et al.
European Journal of Clinical Investigation|May 16, 2019
Baseline hs-CRP predicts hypertension remission in metabolic syndromeFederico Carbone, Edorado Elia, Matteo Casula, et al.
European Journal of Clinical Investigation|September 12, 2020
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot studyLara Caserza, Matteo Casula, Edorado Elia, et al.
European Journal of Clinical Investigation|January 24, 2024
Osteopontin is associated with neutrophil extracellular trap formation in elderly patients with severe sepsisMaria Bertolotto, Daniela Verzola, Paola Contini, et al.
Annals of Neurology|August 7, 2020
Non-Motor Symptoms in Parkinson's Disease are Reduced by NabiloneMarina Peball, Florian Krismer, Hans-Günther Knaus, et al.
Vascular Pharmacology|December 23, 2014
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathwaysFederico Carbone, Nicolas Vuilleumier, Maria Bertolotto, et al.
European Journal of Internal Medicine|July 21, 2016
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial proceduresFabio Rigamonti, Baris Gencer, Florian Rey, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 7, 2024
Osteopontin, death and cardiovascular events in stage G3-4 CKD patients: a joint model analysisGraziella D'Arrigo, Federico Carbone, Mercedes Gori, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Lung|March 14, 2024
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung CancerDavide Ramoni, Simona Coco, Giovanni Rossi, et al.
European Journal of Clinical Investigation|May 16, 2019
Baseline hs-CRP predicts hypertension remission in metabolic syndromeFederico Carbone, Edorado Elia, Matteo Casula, et al.
European Journal of Clinical Investigation|September 12, 2020
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot studyLara Caserza, Matteo Casula, Edorado Elia, et al.
European Journal of Clinical Investigation|January 24, 2024
Osteopontin is associated with neutrophil extracellular trap formation in elderly patients with severe sepsisMaria Bertolotto, Daniela Verzola, Paola Contini, et al.
Annals of Neurology|August 7, 2020
Non-Motor Symptoms in Parkinson's Disease are Reduced by NabiloneMarina Peball, Florian Krismer, Hans-Günther Knaus, et al.
Vascular Pharmacology|December 23, 2014
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathwaysFederico Carbone, Nicolas Vuilleumier, Maria Bertolotto, et al.
European Journal of Internal Medicine|July 21, 2016
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial proceduresFabio Rigamonti, Baris Gencer, Florian Rey, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 7, 2024
Osteopontin, death and cardiovascular events in stage G3-4 CKD patients: a joint model analysisGraziella D'Arrigo, Federico Carbone, Mercedes Gori, et al.
Pageof 27